Vimarsana
Biggest News Aggregation in the World

Page 32 - Neuronetics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neuronetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neuronetics Inc Today - Breaking & Trending Today

Neuronetics Gets FDA Clearance for NeuroStar to Treat Anxious Depression - Vimarsana News

Neuronetics Gets FDA Clearance for NeuroStar to Treat Anxious Depression

By Chris Wack Neuronetics Inc. said it received clearance from the U.S. Food and Drug Administration for a new indication for its transcranial magnetic stimulation system, NeuroStar Advanced...

Neuronetics: NeuroStar Therapy For Mental Health Gets FDA Clearance For Anxious Depression Treatment - Vimarsana News

Neuronetics: NeuroStar Therapy For Mental Health Gets FDA Clearance For Anxious Depression Treatment

(RTTNews) - Neuronetics Inc. (STIM) said that it has received clearance from the U.S. Food and Drug Administration for a new indication for its tr...

TMS Device NeuroStar Cleared for Anxious Depression - Vimarsana News

TMS Device NeuroStar Cleared for Anxious Depression

The FDA has cleared NeuroStar Advanced Therapy for Mental Health to treat anxiety symptoms in adults with major depressive disorder.

Source: empr.com
Deep Brain Stimulation Devices Market Anticipated to Expand at a CAGR of 15.5% during the Forecast Period 2026 - Vimarsana News

Deep Brain Stimulation Devices Market Anticipated to Expand at a CAGR of 15.5% during the Forecast Period 2026

Deep brain stimulation devices market was valued at $881.9 million in 2018, and is projected to reach $2,802.6 million by 2026, registering a CAGR of 15.5%.

Neuronetics Announces Positive TMS Coverage Policies to Expand Patient Access to NeuroStar TMS Therapy for Mental Health - Vimarsana News

Neuronetics Announces Positive TMS Coverage Policies to Expand Patient Access to NeuroStar TMS Therapy for Mental Health

11.07.2022 - Proposed Medicare Coverage through First Coast and Novitas MACs Will Reduce Number of Medication Trials for TMS EligibilityMALVERN, Pa., July 11, 2022 (GLOBE NEWSWIRE) - Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology ...